Prelude Therapeutics Inc Financial Flexibility Index
Prelude Therapeutics Inc financial flexibility index. Prelude Therapeutics Inc (PRLD) has a Financial Flexibility Index of -0.53x as of September 2025. Free cash flow of $-19.11 Million (operating CF $-19.11 Million minus capex $0.00) represents -1% of total liabilities ($36.22 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Prelude Therapeutics Inc (2018–2024)
Financial flexibility index of Prelude Therapeutics Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Prelude Therapeutics Inc across 7 annual periods. Explore Prelude Therapeutics Inc (PRLD) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Prelude Therapeutics Inc Financial Flexibility Index by Year (2018–2024)
Prelude Therapeutics Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Prelude Therapeutics Inc. For the full cash flow conversion analysis, see Prelude Therapeutics Inc (PRLD) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.32x | $-102.12 Million | $-102.89 Million | $44.06 Million | ▲ +9.2% |
| 2023 | -2.55x | $-103.55 Million | $-107.06 Million | $40.58 Million | ▲ +20.8% |
| 2022 | -3.22x | $-80.71 Million | $-83.73 Million | $25.06 Million | ▲ +23.9% |
| 2021 | -4.23x | $-81.21 Million | $-83.53 Million | $19.20 Million | ▼ -5.9% |
| 2020 | -3.99x | $-45.56 Million | $-46.18 Million | $11.41 Million | ▼ -1044.0% |
| 2019 | -0.35x | $-24.89 Million | $-25.66 Million | $71.28 Million | ▼ -9.9% |
| 2018 | -0.32x | $-12.43 Million | $-12.95 Million | $39.10 Million | — |